CA2328495A1 - Vaccine for pseudomonas aeruginosa - Google Patents

Vaccine for pseudomonas aeruginosa Download PDF

Info

Publication number
CA2328495A1
CA2328495A1 CA002328495A CA2328495A CA2328495A1 CA 2328495 A1 CA2328495 A1 CA 2328495A1 CA 002328495 A CA002328495 A CA 002328495A CA 2328495 A CA2328495 A CA 2328495A CA 2328495 A1 CA2328495 A1 CA 2328495A1
Authority
CA
Canada
Prior art keywords
peptide
pak
pao
seq
antiserum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002328495A
Other languages
English (en)
French (fr)
Inventor
Robert S. Hodges
Randall T. Irvin
Paul J. Cachia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2328495A1 publication Critical patent/CA2328495A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002328495A 1998-05-06 1999-05-06 Vaccine for pseudomonas aeruginosa Abandoned CA2328495A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8444498P 1998-05-06 1998-05-06
US60/084,444 1998-05-06
PCT/CA1999/000366 WO1999057142A2 (en) 1998-05-06 1999-05-06 Vaccine for $i(pseudomonas aeruginosa)

Publications (1)

Publication Number Publication Date
CA2328495A1 true CA2328495A1 (en) 1999-11-11

Family

ID=22185008

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002328495A Abandoned CA2328495A1 (en) 1998-05-06 1999-05-06 Vaccine for pseudomonas aeruginosa

Country Status (6)

Country Link
US (2) US6541007B1 (https=)
EP (1) EP1082342A2 (https=)
JP (1) JP2002513802A (https=)
AU (1) AU758235B2 (https=)
CA (1) CA2328495A1 (https=)
WO (1) WO1999057142A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999057142A2 (en) * 1998-05-06 1999-11-11 The Governors Of The University Of Alberta Vaccine for $i(pseudomonas aeruginosa)
US20030228324A1 (en) * 1999-05-06 2003-12-11 Malcolm Andrew J. Peptide compositions and methods of producing and using same
US7314625B2 (en) 2000-12-21 2008-01-01 The United States As Represented By The Secretary Of The Department Of Health And Human Services Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequences
AU2002340683C1 (en) * 2001-11-13 2009-11-12 Id Biomedical Corporation Of Quebec Polypeptides of pseudomonas aeruginosa
EP1790659B1 (en) 2001-11-13 2013-07-31 ID Biomedical Corporation Polypeptides of pseudomonas aeruginosa
CA2571673A1 (en) * 2004-06-28 2006-01-05 Proteome Systems Intellectual Property Pty Ltd Novel methods of diagnosis of treatment of p. aeruginosa infection and reagents therefor
CA2583226A1 (en) 2004-10-04 2006-04-20 Trinity Biosystems, Inc. Methods and compositions for immunizing against pseudomonas infection
EP1919494A4 (en) * 2005-07-22 2011-11-09 Univ Colorado Regents NON-TOXIC BIOFUEL HEMMER
WO2007093177A2 (en) * 2006-02-14 2007-08-23 Vladimir Berezin Metallothionein-derived peptide fragments
RU2553557C2 (ru) * 2013-07-08 2015-06-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Способ изготовления вакцины, ассоциированной против псевдомоноза и вирусной геморрагической болезни кроликов
EP3122900A1 (en) 2014-03-24 2017-02-01 F. Hoffmann-La Roche AG Cancer treatment with c-met antagonists and correlation of the latter with hgf expression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6075181A (en) * 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5223604A (en) * 1991-06-25 1993-06-29 S.P.I. Synthetic Peptides Incorporated Pseudomonas exoenzyme s peptide composition and method
WO1999057142A2 (en) * 1998-05-06 1999-11-11 The Governors Of The University Of Alberta Vaccine for $i(pseudomonas aeruginosa)

Also Published As

Publication number Publication date
AU3591099A (en) 1999-11-23
JP2002513802A (ja) 2002-05-14
EP1082342A2 (en) 2001-03-14
WO1999057142A3 (en) 2000-02-03
AU758235B2 (en) 2003-03-20
US6541007B1 (en) 2003-04-01
US20030211114A1 (en) 2003-11-13
WO1999057142A2 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
US20030021795A1 (en) Use of coiled-coil structural scaffold to generate structure-specific peptides
SK287456B6 (sk) Povrchový proteín Neisseria meningitidis rezistentný voči proteináze K
Forest et al. Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies
AU758235B2 (en) Vaccine for Pseudomonas aeruginosa
US5223604A (en) Pseudomonas exoenzyme s peptide composition and method
US5985277A (en) Antibodies to bacterial stress proteins
Cachia et al. The use of synthetic peptides in the design of a consensus sequence vaccine for Pseudomonas aeruginosa
US6004562A (en) Outer membrane protein B1 of Moraxella catarrhalis
US20030228324A1 (en) Peptide compositions and methods of producing and using same
JP4081140B2 (ja) 非耐熱性エンテロトキシンとコレラトキシンｂサブユニットの雑種分子
US7501132B2 (en) Multiple antigenic peptides immunogenic against Streptococcus pneumonia
JP2762310B2 (ja) ストレプトコッカルｍプロテイン由来の合成ペプタイド及び当該ペプタイドから調製されたワクチン
EP0567470A1 (en) Pseudomonas peptide composition and method for producing the same
US4695562A (en) Synthetic peptide compounds
Panezutti et al. Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies
Olson et al. Identification of functional epitopes of Pseudomonas aeruginosa exotoxin A using synthetic peptides and subclone products
US7189405B1 (en) Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
WO1994008013A9 (en) Pilin variants and uses thereof
WO2004041182A2 (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
van Doom et al. Characterization and detection of the 40 kDa fimbrial subunit of Bacteroides fragilis BE1
CA2262893C (en) Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
Ibsen et al. Identification of B-cell epitopes on the S4 subunit of pertussis toxin
IL167780A (en) Uspa1 ligand and uses thereof
CN100387718C (zh) 抗蛋白酶k降解的脑膜炎奈瑟氏球菌表面蛋白
Sardiñas et al. Anti-PorA antibodies elicited by immunization with peptides conjugated to P64k

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued